Sample QC-transitioning From The Bioanalyzer To Newer Solutions

Join our upcoming seminar on Agilent sample QC solutions, where we bring together expert insights and real-world customer experiences to explore the evolving landscape of nucleic acid quality control.

Following a brief introduction by our product specialist, customers will share first hand perspectives on their transition journeys.

From Bioanalyzer to TapeStation, and from Bioanalyzer to Fragment Analyzer, highlighting key decision drivers, performance gains, and practical lessons learned.

This interactive session offers a unique opportunity to understand how leading laboratories are optimizing workflows, improving data quality, and scaling their operations with Agilent technologies.

Topics covered in the future webinars include instrument transition experiences, selecting the right platform, advanced Fragment Analyzer applications, and innovative uses of ProteoAnalyzer across multiple industries.

Future webinar dates to be released soon

• Webinar  2 - Hear how laboratories use the Agilent TapeStation, Fragment Analyzer, and FEMTO Pulse systems for different nucleic acid QC applications. Customer speakers will share practical experiences, instrument selection criteria, and best practices for optimizing workflows, data quality, and efficiency.
• Webinar 3 - In this session you will discover how the Agilent Fragment Analyzer goes beyond routine nucleic acid QC to power advanced applications.
• Webinar 4 - We explore how the Agilent ProteoAnalyzer supports reliable, reproducible protein analysis across diverse applications. 

Presenter: Romana Bischl (Head of CRO Services, TAmiRNA)

Romana is Head of CRO Services at TAmiRNA, bringing extensive expertise in cancer immunotherapy, molecular biotechnology, and preclinical development. With a background in leading in vivo and in vitro studies, scRNA-seq analysis, and project coordination, she combines scientific rigour with strategic leadership.

Romana holds an MSc in Molecular Biotechnology from FH Campus Wien and pursued her PhD research in immuno-oncology at the Medical University of Vienna. Prior to joining TAmiRNA, she led preclinical development projects at Hookipa Biotech. At TAmiRNA, she oversees contract research services with a focus on innovation, quality, and client collaboration.

Presenter: Alexandra Wagner, MSc (Scientist, TAmiRNA GmbH · Vienna, Austria)

Alexandra Wagner holds a Master’s degree in Molecular Biosciences from Heidelberg University and is currently a doctoral researcher at TAmiRNA.

She has more than five years of experience in next-generation sequencing, lab automation, and molecular diagnostics. Alexandra’s work focuses on advancing small RNA sequencing workflows through experimental research and computational approaches, while she also leads the product management for TAmiRNA’s miND® spike-in technology.

Presenter: Daniela Belamarić (PhD, Lead Scientist, Selvita Ltd)

Daniela graduated in molecular biology from the Faculty of Science at the University of Zagreb in 1998 and completed her PhD in Biology at the Technical University of Munich in 2003.

She has more recently been working within the cellular and tissue biology field, using a wide range of techniques (e.g., RNA/DNA isolation and quantification, ELISA, Luminex, MSD, WES, High Content Imaging, Live Cell Imaging, Live Tissue precision cutting, etc.).

Presenter: Samina Kaufmann (Product Specialist, Agilent Technologies)

Samina Kaufmann is a seasoned Product Specialist for Sample QC in EMEAI. She brings a wealth of knowledge and expertise in the sample QC portfolio, including the Fragment Analyzer, TapeStation, FEMTO Pulse, and Proteo Analyzer etc.

While studying Marketing, Samina played a pivotal role in building up Advanced Analytical, the former manufacturer of today’s parallel capillary electrophoresis instrument portfolio, which was acquired by Agilent in 2018. This experience has given her a unique technical expertise, product knowledge and the perspective on the evolution of the industry and the tools it employs.

Presenter: Dr. Martin Judex (Channel Partner Manager DGG, Agilent Technologies)

After studying Biology at the University of Regensburg in Germany, Martin earned his PhD at the University Hospital Regensburg, where he focused on gene expression studies in samples from patients with rheumatoid arthritis. He continued this research as a postdoctoral fellow in San Diego, USA, and later in Munich, Germany, before beginning his sales career at Stratagene.

When Stratagene was acquired by Agilent, Martin advanced through several sales positions within the company. He currently serves as Channel Partner Manager for Eastern European countries—initially for Genomics, and since 2024 also for Pathology.